Despite these differences, resistin’s role in metabolic and CVD has been widely studied and is recognized as a key mediator of inflammation and metabolic disturbances associated with obesity and T2DM. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.